Sodium Chloride: Clinical Trials

609 trials of Sodium Chloride, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

338 completed, 79 unknown, 66 terminated, 53 recruiting. 609 Phase 3, 132 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 3609Completed 338, Unknown 79, Terminated 66, Recruiting 53, Not yet recruiting 30, Withdrawn 17, Active not recruiting 16, Enrolling by invitation 7, Suspended 3
Phase 2132Completed 72, Unknown 22, Terminated 12, Recruiting 9, Not yet recruiting 7, Withdrawn 5, Active not recruiting 4, Enrolling by invitation 1

Follow Sodium Chloride: new trials by email Literature Review of Sodium Chloride trials Research Report on Sodium Chloride

Trials (filtered) newest first · largest first

All 609 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Aspirin in Acute Pneumonia in the Elderly: a Multicenter, Double-blind, Randomized, Placebo-controlled Trial.
Acetylsalicylic acid/Aspirin (100 mg), Placebo acetylsalicylic acid (100 mg) / 0.9% sodium chloride - Acute Pneumonia, Elderly Person
Phase 3Not yet recruitingCentre Hospitalier Universitaire Dijon6002028-07-012026-09-24
Echinocandin Added to Standard Treatment for Severe Pneumocystis Pneumonia
Echinocandins, Placebo (0.9% Sodium chloride) infusion - Pneumocystis Jirovecii Pneumonia
Phase 3Not yet recruitingMcGill University Health Centre/Research Institute of the McGill University Health Centre4162027-04-012026-10-28
A Study to Evaluate the Maintenance of Efficacy and Long-term Safety of CBL-514 Injection for Reducing Subcutaneous Fat (Stage 1)
CBL-514 Injection, 0.9 % sodium chloride - Subcutaneous Fat
Phase 3Not yet recruitingCaliway Biopharmaceuticals Co., Ltd.3002026-12-012026-10-19
Investigation of Growth Hormone and Platelet-Rich Plasma on Joint Health
Intra-Articular Injection of Growth Hormone and Platelet-Rich Plasma, Saline (NaCl 0,9 %) (placebo) - Arthritis Ankle, Arthritis Knee
Phase 2 / Phase 3Not yet recruitingIntegrant Pty Ltd1922026-11-012026-08-26
A Clinical Trial Evaluating the Efficacy and Safety of Local Infiltration of RF16001 for Injection for Analgesia After Total Hip Arthroplasty in China
RF16001 for injection, Ropivacaine hydrochloride injection, 0.9% sodium chloride injection - Pain After Abdominal Surgery
Phase 3Enrolling by invitationThe Third Xiangya Hospital of Central South University3002026-10-102026-10-14
Intrauterine G-CSF Infusion for Thin Endometrium
Granulocyte Colony-Stimulating Factor(G-CSF), Normal Saline - Thin Endometrium, Female Infertility
Phase 3Not yet recruitingNanjing University6202026-10-012026-07-09
MAGNEsium With meToprolol for Rate Control In Atrial Fibrillation
Magnesium Sulfate 2g, Magnesium Sulfate 4g, Saline (0.9% NaCl) - Atrial Flutter With Rapid Ventricular Response
Phase 3Not yet recruitingWake Forest University Health Sciences1962026-10-012026-06-29
Oral or Topical Catechins for Radiation Dermatitis
Epicatechin, Epigallocatechin Gallate (EGCG), Microcrystalline Cellulose NF (placebo) - Radiation Dermatitis Acute, Radiation Dermatitis
Phase 3Enrolling by invitationCARLOS FRANCISCO SAAVEDRA GARCIA1622026-10-012026-09-11
A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat ( SUPREME-02 )
CBL-514 Injection, 0.9% Sodium Chloride - Subcutaneous Fat
Phase 3Not yet recruitingCaliway Biopharmaceuticals Co., Ltd.3202026-10-012026-10-20
THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: THE PROMISE DOUBLE BLIND, PHASE III, RANDOMIZED CONTROLLED CLINICAL TRIAL
Meropenem Infusion, Sodium Chloride (NaCl) 0.9 % - Sepsis
Phase 3RecruitingHellenic Institute for the Study of Sepsis3982026-10-012026-11-03
A Study to Evaluate the Efficacy and Safety of CBL-514 Injection for Reducing Subcutaneous Fat
CBL-514 Injection, 0.9% Sodium Chloride - Subcutaneous Fat
Phase 3RecruitingCaliway Biopharmaceuticals Co., Ltd.3202026-09-012026-10-19
Outpatient Hypertonic Saline and Loop Diuretic Combination Therapy in Cardiorenal
Hypertonic sodium chloride 10%, Sodium Chloride 0.9%, Furosemide intravenous solution - Heart Failure, Renal Disease, Chronic
Phase 3Not yet recruitingUniversity of Monastir602026-09-012026-07-15
Early Corticosteroids in Severe Influenza Pneumonia
Dexametasone, Sodium chloride 0.9% (placebo) - Severe Influenza, Intensive Care (ICU)
Phase 3Not yet recruitingCentre Hospitalier Régional Metz-Thionville5442026-09-012026-08-28
Efficacy of Intravenous Dexamethasone in Prolonging the Duration of Spinal Anesthesia With Chloroprocaine in Knee Arthroscopy
Sodium Chloride 0.9%, Dexamethasone, Chloroprocaine Injection [Clorotekal] - Knee Arthroscopy
Phase 3Not yet recruitingCMC Ambroise Paré602026-09-012026-06-29
Effect of Trilaciclib in the Prevention of Myelosupression in Subjects With Limited-stage Small Cell Lung Cancer
Trilaciclib, Saline (0.9% NaCl) - Limited Stage Small Cell Lung Cancer
Phase 3RecruitingPharmacosmos A/S1202026-09-012026-10-02
Intravenous Lidocaine to Prevent Post-Fundal Pressure Headache During Cesarean Section
Lidocaine IV, Saline 0.9% - Intravenous Lidocaine, Fundal Pressure
Phase 3RecruitingTanta University6802026-07-012026-07-06
Subcutaneous Calcitonin in Acute Herpes Zoster
Calcitonin, Saline - Calcitonin, Subcutaneous
Phase 3RecruitingTanta University1682026-07-012026-07-06
Clinical Trial With Aprotinin in the Acute Respiratory Distress Syndrome Treatment
Aprotinin (inhaled), Placebo (Sodium Chloride) - Acute Respiratory Distress Syndrome (ARDS)
Phase 3RecruitingFundacion del Hospital Nacional de Paraplejicos para la Investigacion y la Integracion1562026-06-182026-07-15
Investigating the Efficacy of Tranexamic Acid as a Prophylactic Agent in Reducing Postpartum Hemorrhage Among Patients Undergoing Cesarean Section in SQUH
tranexamic acid (1 g diluted in 100 mL of 0.9% saline, Normal (0.9%) saline - Post Partum Haemorrhage
Phase 3Not yet recruitingSultan Qaboos University882026-05-012026-04-01
Comparative Efficacy Of 4 mg VS. 8 mg Submucosal Dexamethasone In Postoperative Pain Management After Dental Implant Surgery: A Randomized Double-Blind Controlled Clinical Trial
Dexamethasone 4 Mg/mL Injectable Solution, Dexamethasone 8Mg Solution for Injection, Saline (NaCl 0,9 %) (placebo) - Postoperative Pain
Phase 3RecruitingOman Ministry of Health1382026-03-252026-03-30

Showing 20 of 609. Sign in to see all of them.

Conditions studied

Pain, Postoperative (33)  ·  COVID-19 (26)  ·  Pain (26)  ·  Osteoarthritis (20)  ·  Agnosia (17)  ·  Osteoarthritis, Knee (16)  ·  Sepsis (13)  ·  Acute Kidney Injury (12)  ·  Hemorrhage (11)  ·  Breast Neoplasms (10)  ·  Postpartum Hemorrhage (9)  ·  Postoperative Nausea and Vomiting (8)  ·  Wounds and Injuries (8)  ·  Angioedemas, Hereditary (7)  ·  Atrial Fibrillation (7)

Sponsors

Assiut University (14)  ·  Pfizer (9)  ·  Copenhagen University Hospital, Rigshospitalet (8)  ·  Assistance Publique - Hôpitaux de Paris (7)  ·  Cairo University (6)  ·  London School of Hygiene and Tropical Medicine (5)  ·  Qingyuan Zhan (5)  ·  Tanta University (5)  ·  University Health Network, Toronto (5)  ·  Ain Shams University (4)  ·  Ampio Pharmaceuticals. Inc. (4)  ·  London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (4)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (4)  ·  Meir Medical Center (4)  ·  Merck Sharp & Dohme LLC (4)

Countries

United States (180)  ·  Canada (65)  ·  France (59)  ·  Germany (47)  ·  Egypt (40)  ·  Denmark (38)  ·  Spain (38)  ·  Australia (34)  ·  United Kingdom (34)  ·  Italy (33)  ·  China (32)  ·  Belgium (28)  ·  Brazil (26)  ·  Poland (24)  ·  Netherlands (23)

Top investigators

Viktoria Lindberg-Larsen, MD (6)  ·  Anne Sheu (3)  ·  Omer Mei Dan, Dr (3)  ·  Pablo M Ingelmo, MD (3)  ·  Stuart D Miller, MD (3)  ·  Yi Ba, MD.PHD (3)  ·  Adrian Vella, MD (2)  ·  Anne Marie Rosendahl Madsen, MD (2)  ·  Avroy A. Fanaroff, MD (2)  ·  Barbara J. Stoll, MD (2)

Results publications

PMID 20554319, PMID 39162220, PMID 42159953, PMID 17180268, PMID 18633034, PMID 20487038, PMID 20818886, PMID 20920772, PMID 21883197, PMID 22900785, PMID 23312695, PMID 25080874, PMID 25500317, PMID 26452709, PMID 28284978, PMID 29156068, PMID 31112399, PMID 32492040, PMID 33026630, PMID 33026631, PMID 38470985, PMID 39186385, PMID 39301879, PMID 10582782, PMID 10625862, PMID 10691234, PMID 10910490, PMID 10910857, PMID 11020770, PMID 11150359, PMID 12010907, PMID 12114906, PMID 12219057, PMID 12563043, PMID 12826855, PMID 15023840, PMID 15121942, PMID 15150204, PMID 15316237, PMID 15317861, PMID 15510034, PMID 15983467, PMID 16352625, PMID 16508405, PMID 16698416, PMID 17405780, PMID 1777459, PMID 17882910, PMID 18347861, PMID 18702902

NIH funding

2019 (10), 2023 (7), 2015 (6), 2016 (6), 2014 (4), 2017 (4), 2008 (3), 2009 (3), 2018 (3), R01DK126206 (3), 2025 (2), M01RR000070 (2), M01RR000750 (2), M01RR000997 (2), M01RR006022 (2)